Using the crystal structure of the ACTB monomer, we mapped the amino acid alterations in ACTB and ACTG1 resulting from missense mutations observed in the DLBCL and multiple myeloma patient samples (Figure 4a,b). Here, ACTB is linked to AL amyloidosis.